Brochure

Cited Sources

  1. Gallily, Ruth, Zhannah Yekhtin, and Lumír Ondřej Hanuš. "Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol." Pharmacol Pharm 6.2 (2015): 75-85.
  2. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Philpott HT et al. Pain. 2017 Dec;158(12):2442-2451.
  3. Is cannabis an effective treatment for joint pain? Miller RJ et al. Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 107(5):59-67.
  4. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon. Couch DG et al. Clin Sci (Lond). 2017 Oct 25;131(21):2611-2626.
  5. Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury. Wang Y et al. Sci Rep. 2017 Sep 21;7(1):12064.
  6. Cannabinoid Regulation of Acute and Anticipatory Nausea. Rock EM et al. Cannabis Cannabinoid Res. 2016 Apr 1;1(1):113-121.
  7. Cannabinoids suppress acute and anticipatory nausea in preclinical rat models of conditioned gaping. Parker LA et al. Clin Pharmacol Ther. 2015 Jun;97(6):559-61.
  8. Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders. Lee JLC et al. Br J Pharmacol. 2017 Oct;174(19):3242-3256.
  9. Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. Campos AC et al. Front Pharmacol. 2017 May 23;8:269.
  10. Efficacy and safety of cannabis for treating children with refractory epilepsy. Neale M et al. Nurs Child Young People. 2017 Sep 11;29(7):32-37.
  11. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Kaplan JS et al. Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11229-11234.
  12. In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease. Watt G, Karl T. Front. Pharmacol., 03 February 2017.
  13. Cannabidiol Reduces Brain Damage and Improves Functional Recovery After Acute Hypoxia-Ischemia in Newborn Pigs. Hector Lafuente, et al. Pediatric Research 70, 272–277 (2011).
  14. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Pazos MR, et al. J.Neuropharmacology. 2012 Oct;63(5):776-83. doi: 10.1016/j.neuropharm.2012.05.034.
  15. Cannabidiol, neuroprotection and neuropsychiatric disorders. Campos AC, et al. Pharmacol Res. 2016 Oct;112:119-127. doi: 10.1016/j.phrs.2016.01.033.
  16. Pharmacological Management of Chronic Neuropathic Pain – Consensus Statement and Guidelines from the Canadian Pain Society. DE Moulin, AJ Clark, I Gilron, et al.,  Pain Research and Management, vol. 12, no. 1, pp. 13-21, 2007.
  17. Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Weiss L, et al., Neuropharmacology, Volume 54, Issue 1, 2008, Pages 244-249.
  18. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Zimmer A, et al., Proceedings of the National Academy of Sciences May 1999, 96 (10) 5780-5785.
  19. The peripheral cannabinoid receptor knockout mice: an update. Buckley, N. E., British Journal of Pharmacology, 153: 309–318.
  20. Cannabinoids in the management of difficult to treat pain. Russo EB. Therapeutics and Clinical Risk Management. 2008;4(1):245-259.
  21. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Russo, E. B., British Journal of Pharmacology, 163: 1344–1364.